Media Mosiac Gov Solutions Book a Strategy Call
Gov.MediaMosiac β€Ί GovCon News
πŸ› GovCon Intel Opportunities Presolicitations Contract Awards Award Notices Grants Events Regulatory Search πŸ“ Insights
← Back to Regulatory Updates

Schedules of Controlled Substances: Placement of Tianeptine in Schedule I

Proposed Rule πŸ’¬ Comment by Aug 7 (7d left)
Justice Department, Drug Enforcement Administration
Proposed Rule
July 8, 2026
2026-13821
21 CFR 1308
August 7, 2026 (7 days left)

πŸ“„ Summary

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.
🎯 Get GovCon Intel Free β†’